How many days should I stop Acitrome (dicoumarol) oral anticoagulation before surgery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Preoperative Management of Acitrome (Dicoumarol)

Stop Acitrome (dicoumarol) 5 days before surgery for procedures with low-to-moderate bleeding risk, and ensure your INR is <1.2-1.5 before proceeding. 1, 2, 3, 4

Timing Based on Surgical Bleeding Risk

Standard/Major Surgery (Intermediate-to-High Bleeding Risk)

  • Stop dicoumarol 5 days before surgery 3, 4
  • Verify INR <1.5 for low bleeding risk procedures
  • Verify INR <1.2 for intermediate-to-high bleeding risk procedures 1, 2

Minor Procedures (Low Bleeding Risk)

For minor dental, dermatologic, or cataract procedures:

  • Either continue dicoumarol with local hemostatic measures, OR
  • Stop 2-3 days before the procedure 3

Neuraxial Procedures (Highest Risk)

  • Stop 5 days before procedure AND confirm INR ≤1.2 2
  • This is the most conservative approach given catastrophic bleeding consequences

Bridging Anticoagulation Decision

High thromboembolism risk patients (CHADS₂ score ≥3, mechanical heart valve, stroke/TIA within 3 months, rheumatic heart disease):

  • Start LMWH or UFH when INR drops below therapeutic range 1, 3
  • Stop LMWH 24 hours before surgery 1, 3
  • Stop UFH 4-6 hours before surgery 1, 3

Low thromboembolism risk patients:

  • No bridging recommended 3
  • Bridging increases bleeding risk without clear benefit

Postoperative Resumption

Resume dicoumarol 12-24 hours after surgery (evening of surgery or next morning) when adequate hemostasis is established 3, 4:

  • Low bleeding risk procedures: 24-48 hours postoperatively 1
  • High bleeding risk procedures: 48-72 hours postoperatively 1

If bridging was used:

  • Restart LMWH at prophylactic doses for first 24-72 hours 1
  • Then increase to therapeutic doses until INR reaches therapeutic range 1
  • Continue bridging until INR is therapeutic, then discontinue heparin

Critical Pitfalls to Avoid

  1. Don't bridge low-risk patients - Recent evidence shows bridging increases bleeding without reducing thromboembolism 3

  2. Don't stop too close to surgery - Stopping <5 days risks inadequate anticoagulation reversal, particularly in elderly patients or those on low warfarin doses 4

  3. Don't delay resumption unnecessarily - Delayed restart (>24 hours) increases thromboembolism risk without clear bleeding benefit 4

  4. Account for acenocoumarol differences - If using acenocoumarol instead of warfarin/dicoumarol, only 2-3 days interruption needed 2, 4

Special Considerations

The most recent French guidelines 2 from 2025 provide the most conservative neuraxial procedure guidance, while the 2022 ACCP guidelines 4 offer the most comprehensive perioperative framework. Both strongly support the 5-day interruption standard established in 2012 3 and reinforced by the 2014 Canadian guidelines 1.

For patients with renal impairment, hepatic dysfunction, or unclear medication history, measure INR the day before surgery to confirm adequate reversal 2.

Related Questions

In a patient with atrial fibrillation taking apixaban (Eliquis), how many days should the medication be discontinued prior to surgical procedures?
In a paraplegic patient taking rivaroxaban who is scheduled for surgery, what is the recommended peri‑operative anticoagulation strategy, including when to stop rivaroxaban, whether to use heparin bridging, and postoperative venous thromboembolism prophylaxis?
Can a patient on Eliquis (apixaban) go to the Operating Room (OR)?
What is the perioperative management plan for patients on chronic anticoagulation (warfarin and direct oral anticoagulants) undergoing surgery, including timing of drug discontinuation, INR targets, bridging with low‑molecular‑weight heparin, and resumption of therapy?
What is the recommended timing for discontinuing acenocoumarol and reversing its anticoagulant effect before emergency orthopedic surgery?
For a 9-year-old child weighing 39 kg, can I prescribe 30 drops of ibuprofen (100 mg/mL)?
Which soft‑tissue lesions of the external auditory canal can be diagnosed on computed tomography (CT) with a reasonable degree of confidence?
In a 34‑year‑old woman with seborrheic dermatitis, large facial pores, follicular back acne, and persistent severe scalp and ear itching with dry scaly patches despite prior topical steroid use, what is the next step in treatment?
Is a patient with 4 mm disc bulges at L3‑5 and L5‑S1 causing mild anterior thecal‑sac effacement, who underwent bilateral facet ablation 12 days ago, still a suitable candidate for sacrocolpopexy?
Which Z‑drug (zolpidem, eszopiclone, or zaleplon) is safe for long‑term use?
What is the appropriate management for distal (rectal) fecal impaction?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.